ROOT OF SKIN™ Skincare Products Sell Out on Every QVC Japan Show in 2019
IRVINE, Calif. – January 8, 2020 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces New Positive Phase 2 Glioblastoma Data at SITC Annual Meeting Podium Presentation
IRVINE, Calif. – November 12, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical’s Phase 2 Clinical Trial to be Presented at SITC Annual Meeting
IRVINE, Calif. – November 8, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical to Present at Upcoming Regenerative Medicine, Oncology and Investor Conferences in November
IRVINE, Calif. – November 1, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated with AIVITA Immunotherapy
IRVINE, Calif. – October 30, 2019 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications,…
Brain Cancer Patients Display Appropriate Immune Responses and Decreasing Tumor Biomarkers in AIVITA Biomedical’s Phase 2 Clinical Trial
IRVINE, Calif. – October 24, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies
IRVINE, Calif. – October 17, 2019 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications,…
ROOT OF SKIN™ Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan
IRVINE, Calif. – October 15, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces Publication Concerning a Predictive Biomarker for Melanoma Patients Treated with the Company’s Platform Immunotherapy
IRVINE, Calif. – October 2, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA CEO Dr. Hans Keirstead Honored as One of Canada’s ‘Seven Wonderers’ at Beakerhead Festival
IRVINE, Calif. – October 1, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…